Reasons Why Combination Therapy Should Be the New Standard of Care to Achieve the LDL-Cholesterol Targets : Lipid-lowering combination therapy.

Curr Cardiol Rep · 2020 · PMC7305062 · PMID 32562015

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

After several neutral-outcome studies [ 40 ], the Reduce-it study showed that 4 g a day of icosapent ethyl produced a highly significant impact on cardiovascular events.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.